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endoplasmic reticulum stress 
differentially modulates the IL-6 
family of cytokines in murine 
astrocytes and macrophages
Cristina L. Sanchez  1, Savannah G. Sims1, John D. Nowery1 & Gordon P. Meares  1,2*
In many diseases, misfolded proteins accumulate within the endoplasmic reticulum (ER), leading to ER 
stress. In response, the cell initiates the unfolded protein response (UPR) to reestablish homeostasis. 
Additionally, in response to ER stress, various cell types mount an inflammatory response involving 
interleukin (IL)-6. While IL-6 has been widely studied, the impact of ER stress on other members of the 
IL-6 cytokine family, including oncostatin (OSM), IL-11, ciliary neurotrophic factor (CNTF), and leukemia 
inhibitor factor (LIF) remains to be elucidated. Here, we have examined the expression of the IL-6 
family cytokines in response to pharmacologically-induced ER stress in astrocytes and macrophages, 
which express IL-6 in response to ER stress through different mechanisms. Our findings indicate that, 
in astrocytes, ER stress regulates mRNA expression of the IL-6 family of cytokines that is, in part, 
mediated by PKR-like ER kinase (PERK) and Janus kinase (JAK) 1. Additionally, in astrocytes, CNTF 
expression was suppressed through a PERK-dependent mechanism. Macrophages display a different 
profile of expression of the IL-6 family that is largely independent of PERK. However, IL-6 expression in 
macrophages was dependent on JAK signaling. Overall, this study demonstrates the cell-specific and 
differential mechanisms controlling expression of the IL-6 family of cytokines in response to ER stress.
The interleukin (IL)-6 family of cytokines has pleiotropic effects on immune function, metabolism, development, 
tissue repair, and neural function. This family of cytokines include IL-6, IL-11, oncostatin M (OSM), leukemia 
inhibitory factor (LIF), cardiotrophin (CT-1), and cardiotrophin-like cytokine (CLC) that bind to their respective 
receptors. Common among these proteins is the use of the co-receptor glycoprotein (gp)130 either as a homod-
imer interacting with IL-6R or IL-11R or as a heterodimer with other IL-6 receptor family members to initiate 
intracellular signaling through the Janus kinase (JAK) / signal transducers and activators of transcription (STAT) 
pathway upon receptor ligation1. Cytokine-dependent activation of JAKs (JAK1, JAK2, JAK3 and Tyk2), which 
are tyrosine kinases, leads to phosphorylation-dependent activation of STATs (STAT1, 2, 3, 4, 5a, 5b and 6). STATs 
are latent cytoplasmic transcription factors that, upon phosphorylation, homo- or heterodimerize, translocate 
to the nucleus, and drive gene expression2,3. The IL-6 family signals primarily via activation of STAT3; however, 
other STATs can be activated at lower levels1. STAT activation regulates a wide variety of genes that modulate 
cellular functions such as proliferation, differentiation, and effector functions to shape an immune response.
Given the similarities in intracellular signaling, it is not surprising that the IL-6 cytokines have overlapping 
functions. IL-6, IL-11, OSM, LIF, and CNTF all have the ability to induce an acute phase response4. Despite sim-
ilarities in signaling, the IL-6 family members can also elicit different or even opposite effects. For example, IL-6 
worsens the multiple sclerosis animal model of experimental autoimmune encephalomyelitis (EAE) while CNTF, 
LIF, and IL-11 are protective4–7. Additionally, aberrant IL-6 and JAK/STAT signaling is implicated in several dis-
ease states including autoimmunity and cancer8–10.
The endoplasmic reticulum (ER) is a critical signaling and organizing hub for immune function through 
the regulation of protein folding and secretion, Ca2+ levels, and mitochondrial – ER contacts11,12. If the protein 
folding capacity of the ER is disrupted or overwhelmed, excessive misfolded proteins can accumulate within 
the ER lumen leading to ER stress. In response, the cell will initiate the unfolded protein response (UPR) aimed 
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at restoring homeostasis13. The UPR signaling cascade is initiated by three sensor molecules; inositol requiring 
enzyme (IRE) 1, protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), and activating transcription 
factor (ATF) 6. The UPR induces activation of these molecules to initiate downstream signaling aimed at restor-
ing homeostasis or initiating apoptosis if the stress is not resolvable14. PERK is a trans-ER membrane serine/
threonine kinase that phosphorylates eukaryotic initiation factor 2α (eIF2α), which leads to selective suppression 
of protein translation. This is an adaptive response to reduce new polypeptides entering the ER to be folded15. 
There is a subset of proteins including transcription factors and chaperones, which are not suppressed, but rather 
increased by P-eIF2α-induced translational suppression. For example, ATF4 and C/EBP homologous protein 
(CHOP) are selectively upregulated in response to UPR activation, and continuous translation of these molecules 
is proapoptotic16. Recently, a small molecule, integrated stress response inhibitor (ISRIB), was identified that 
reverses the ER stress-induced translational block by enhancing eIF2B activity17.
Chronic UPR activation has been reported in many diseases, including diabetes, cancer, and neurodegenera-
tion18–20. Similarly, inflammation is a hallmark of chronic diseases. ER stress can directly promote inflammatory 
gene expression, including proinflammatory cytokines such as IL-621. In macrophages, ER stress-induced IRE1 
activation drives a pathway involving nucleotide-binding oligomerization domain-containing protein (NOD1/2) 
and the transcription factor X-box binding protein 1 (XBP1) leading to IL-6 expression22,23. Astrocytes are the 
most abundant glial cell in the CNS and key regulators of neuroinflammation24. ER stress-induced IL-6 pro-
duction in astrocytes differs from macrophages in that it requires PERK and JAK1, but is independent of IRE1 
and nuclear factor-κB (NF-κB)25,26. Additionally, IL-6 expression in astrocytes does not rely on ATF426, which is 
distinct from endothelial cells that use both ATF4 and XBP127. While ER stress-induced IL-6 expression has been 
Figure 1. Time-course of the IL-6 cytokine family expression in astrocytes during ER stress. (a–e) Wild type 
primary murine astrocytes were stimulated with 1 µM thapsigargin (thaps) or 5 µM tunicamycin (tunic), and 
mRNA expression was analyzed by qPCR at the indicated time points. Untreated (UT). N = 3, *P ≤ 0.05.
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widely studied, far less is known about other members of the IL-6 family. Previous work has shown that ER stress 
in intestinal epithelial cells can promote production of IL-6 and IL-11 that can drive STAT3 phosphorylation in an 
autocrine-dependent fashion28. Here, we have examined the regulation of the IL-6 family of cytokines in primary 
astrocytes and macrophages in response to classic pharmacological inducers for ER stress.
Results and Discussion
To test how ER stress effects the expression of the IL-6 family of cytokines, primary murine astrocytes were stim-
ulated with thapsigargin (thaps) or tunicamycin (tunic) for 2–16 h. As shown in Fig. 1a–d, ER stress transiently 
and significantly increased IL-6, OSM, IL-11, and LIF. In contrast, thaps and tunic significantly suppressed CNTF 
expression (Fig. 1e).
ER stress suppresses protein translation through PERK-dependent phosphorylation of eIF2α15. Therefore, we next 
tested if ER stress could stimulate changes in the IL-6 family of cytokines at the protein level. Primary astrocytes were 
stimulated with thaps or tunic for 24 h and protein levels were measured by ELISA. Consistent with previous reports, 
IL-6 protein was strongly increased. LIF was also modestly increased in response to tunic. However, OSM and IL-11 
were not increased. CNTF levels were reduced, consistent with mRNA data (Fig. 2a). These data indicate that IL-6 is 
not suppressed by translational repression while the expression of OSM, IL-11 and CNTF is prevented. Upregulation of 
OSM and IL-11 mRNA likely reflects an anticipatory response so that the cell is poised to produce these neuroprotec-
tive cytokines29,30 upon resumption of protein translation. One mechanism known to allow translation during eIF2α 
phosphorylation is the presence of an upstream open reading frame (ORF)16. eIF2α phosphorylation reduces the ribo-
somal acquisition of initiator methional-tRNA leading to readthrough of the upstream ORF and increased probability 
of initiating translation at a downstream coding region16. Using in silico analysis, we have identified that both human 
and murine IL-6 contain a predicted upstream ORF that overlaps the translational start site and part of the IL-6 cod-
ing region (Fig. 2b). This organization is similar to CHOP and ATF4 which are translationally regulated by upstream 
ORFs31,32. OSM, LIF and IL-11 do not contain an upstream ORF, while CNTF contains a non-overlapping upstream 
ORF. These data indicate that IL-6 can be translated under both translationally competent and repressed states. To 
confirm that IL-6 is translated and not released from preformed stores, we inhibited translation with cycloheximide 
(CHX). As shown in Fig. 2c, CHX attenuates IL-6 protein production in response to ER stress. These data indicate 
that IL-6 can be translated under conditions in which eIF2α is phosphorylated. These data are consistent with previ-
ous work showing that herpes simplex virus drives protein kinase R-dependent and CHX sensitive IL-6 expression33. 
Importantly, PKR also phosphorylates eIF2α during viral infection34, further supporting that IL-6 translation is resist-
ant to P-eIF2α-mediated repression. We also noted that the upstream ORF shared substantial homology at the amino 
acid level between murine and human sequences. This may indicate a functional role for the product of these ORFs.
Figure 2. Regulation of IL-6 family proteins during ER stress. (a) Wild type primary murine astrocytes were 
stimulated with 1 µM thaps or 5 µM tunic for 24 h. The cell culture media were then analyzed by ELISA. Lower 
limit of quantitation (LLOQ). (b) Illustration of the murine and human IL-6 transcript showing the presence 
of a predicted upstream open reading frame (ORF). (c) Primary astrocytes were treated with cycloheximide 
(CHX) (50 µM) for 30 min followed by the addition of thaps (1 µM) or tunic (5 µM) for 24 h. Media were then 
analyzed by ELISA for IL-6. Data are means ± SD, N = 3, *P ≤ 0.05.
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Next, we examined the impact of ER stress on the expression of the IL-6 family of cytokines in primary mac-
rophages. As shown in Fig. 3a, thaps and tunic increased IL-6 expression as expected. IL-11 was also increased 
by both thaps and tunic, while OSM and LIF were increased only by thaps (Fig. 3b–d). In contrast to astrocytes, 
CNTF was significantly increased in macrophages (Fig. 3e). These data indicate that the expression of the IL-6 
family of cytokines is differentially regulated depending on the stimulus and cell type.
Our previous work has shown that ER stress-induced IL-6 expression is PERK-dependent in astrocytes25. 
To test if PERK also regulates other members of the IL-6 family, PERK was deleted from PERK-floxed astro-
cytes using tamoxifen-inducible cre. As shown in Fig. 4a, PERK was effectively deleted leading to attenuation 
of CHOP expression. The electrophoretic mobility shift of PERK in response to ER stress (Fig. 4a) is consistent 
with hyperphosphorylation and activation35. PERK deletion abrogated ER stress-induced IL-6 expression and 
reduced LIF expression, but had no effect on IL-11 or OSM expression (Fig. 4b–e). PERK deletion also rescued 
ER stress-induced suppression of CNTF expression (Fig. 4f). These data show that PERK drives IL-6 expression 
while also suppressing CNTF. As such, targeting PERK has the potential to reduce the pro-inflammatory effects 
of IL-6 while enhancing CNTF, which has neurotrophic and neuroprotective properties36. Based on our find-
ings that PERK regulates the IL-6 family in astrocytes, we anticipated that translational repression may similarly 
regulate gene expression. To test this, we treated astrocytes with the small molecule ISRIB, which attenuates the 
P-eIF2α-induced translational block37. As shown in Fig. 5a, ISRIB effectively suppresses ER stress-induced ATF4 
expression, consistent with previous findings37. ISRIB potently suppressed ER stress induced IL-6 expression and 
attenuated IL-11 and LIF expression, but had no effect on OSM induction (Fig. 5b–e). Consistent with the effects 
of PERK deletion, ISRIB also partially rescued CNTF expression (Fig. 5f).
To test if PERK has a similar role in macrophages, we again deleted PERK using tamoxifen-inducible cre. 
PERK and CHOP expression were both reduced in the knockout macrophages (Fig. 6a). In contrast to astrocytes, 
Figure 3. Time-course of the IL-6 cytokine family expression in bone marrow-derived (BMD) macrophages 
during ER stress. (a–e) Wild type BMD macrophages were stimulated with 1 µM thapsigargin (thaps) or 5 µM 
tunicamycin (tunic), and mRNA expression was analyzed by qPCR. N = 4, *P ≤ 0.05.
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PERK deletion had a minimal and non-significant effect on ER stress-induced expression of IL-6, OSM, IL-11, 
and CNTF (Fig. 6b–e). We noted that IL-11 was highly variable in macrophages from PERK transgenic animals 
(Fig. 6d), making conclusive evaluation difficult. This may be due to the genetic background of the mice or from 
the pretreatment with tamoxifen. PERK deletion did significantly suppress expression of LIF in macrophages 
(Fig. 6f). These data indicate that astrocytes and macrophages utilize different mechanisms to control expression 
of the IL-6 family of cytokines. These data are consistent with previous work showing that thaps-induced IL-6 
expression is IRE1-dependent in macrophages and is unaffected by PERK inhibition22,23. The molecular basis for 
this cell type-dependent IL-6 regulation is currently unknown. One possibility is that differential epigenetic mod-
ifications allow either PERK- or IRE1-activated transcription factors to preferentially access the IL-6 promoter to 
drive gene expression. Previous work has shown that, in neutrophils, the IL-6 locus undergoes stimulus-induced 
chromosomal remodeling to promote IL-6 transcription. Additionally, the chromatin organization of the IL-6 
locus was found to differ between neutrophils and monocytes38, showing that cell-specific genome structure 
influences IL-6 expression. A similar effect may occur in astrocytes and macrophages resulting in the utilization 
of different transcription factors. We next tested if ISRIB has similar effects as PERK deletion in macrophages. 
As expected, ISRIB had no effect on ER stress-induced IL-6 expression (Fig. 6g). However, ISRIB significantly 
suppressed LIF expression, consistent with PERK deletion (Fig. 6h). Together, these data suggest that PERK acti-
vation and translational suppression influences LIF but not IL-6 expression in macrophages.
Figure 4. PERK-dependent regulation of the IL-6 family in astrocytes. (a) Astrocytes were isolated from PERKfl/fl  
and PERKfl/fl × CAGG-CreERTM littermates. Primary murine astrocytes were pre-treated with 1 μM 4-OH-
tamoxifen for 48 hours to delete PERK. Subsequently, cells were treated with 1 μM thaps and 5 μM tunic for 4 hours 
followed by immunoblotting to confirm PERK deletion. (b–f) Cells were isolated and treated as in (a), and mRNA 
expression was analyzed by qPCR. N = 3–5, *P ≤ 0.05. Full-length blots are presented in Supplementary Fig. 1.
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Previously, we have shown that JAK1 is an important mediator of PERK-dependent inflammatory gene 
expression25. To test if JAK signaling regulates expression of the IL-6 family of cytokines, we used the small mol-
ecule JAK1/2 inhibitor AZD1480. As shown in Fig. 7a, OSM stimulation of astrocytes robustly increases STAT3 
phosphorylation at tyrosine 705, which is completely abrogated by pretreatment with AZD1480. This shows that 
AZD1480 effectively suppresses JAK kinase activity. Next, astrocytes were pretreated with AZD1480 followed 
by stimulation with thaps or tunic. AZD1480 prevented ER stress-induced IL-6 expression (Fig. 7b). AZD1480 
also suppressed the expression of OSM and LIF (Fig. 7c,e) but had no effect on IL-11 or CNTF (Fig. 7d,f). These 
data show that JAK signaling is important for the expression of select members of the IL-6 family but is not 
responsible for suppression of CNTF. Interestingly, AZD1480 also potently suppressed IL-6 induction in mac-
rophages (Fig. 8a) but did not affect other IL-6 family cytokines (Fig. 8b–e). Considering that PERK does not 
stimulate IL-6 expression in macrophages, this suggests that PERK may not signal to JAK1 in macrophages and 
that another pathway engages JAK1 to drive IL-6 expression. The mechanism by which JAK1 is activated in mac-
rophages following ER stress is currently unknown. It is possible that JAK1 is activated secondarily to ER stress 
Figure 5. Translational repression regulates the IL-6 cytokine family in astrocytes. (a) Primary murine 
astrocytes were pre-treated with 0.5 μM ISRIB for 30 minutes prior to ER stress stimulation with 1 μM thaps or 5 
μM tunic for 4 hours followed by immunoblotting. (b–f) Cells were treated as in (a), and mRNA expression was 
analyzed by qPCR. N = 3–4, *P ≤ 0.05. Full-length blots are presented in Supplementary Fig. 2.
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in an autocrine-dependent fashion. In this case, ER stress may quickly induce cytokines that ligate JAK1-coupled 
cytokine receptors leading to canonical activation of JAK/STAT signaling. STAT1 and STAT3 have been shown to 
synergize with NF-κB, which is an important transcription factor driving IL-6 in macrophages39. Thus, cytokine 
Figure 6. PERK-dependent regulation of the IL-6 family in macrophages. Bone marrow-derived macrophages 
were isolated from PERKfl/fl and PERKfl/fl × CAGG-CreERTM littermates. (a) Macrophages were pre-treated 
with 1 μM 4-OH-tamoxifen for 48 hours to delete PERK. Subsequently, cells were treated with 1 μM thaps and 5 
μM tunic for 4 hours followed by immunoblotting. (b–f) Cells were treated as in (a) and mRNA expression was 
analyzed by qPCR. (g,h) Wild-type macrophages were pre-treated with 0.5 μM ISRIB for 30 minutes prior to ER 
stress stimulation with 1 μM thaps or 5 μM tunic for 4 hours followed by qPCR. N = 3–5, *P ≤ 0.05. Full-length 
blots are presented in Supplementary Fig. 3.
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receptor mediated JAK1 activation leading to STAT activation may enhance IRE1-dependent IL-6 production 
in macrophages. Future studies will test these possibilities. Collectively, and summarized in Fig. 9, these data 
indicate that astrocytes and macrophages use different mechanisms to regulate the IL-6 family of cytokines in 
response to ER stress.
Methods
Animals. Wild type C57BL/6J, PERK floxed and CAGG-CreERTM mice were purchased from the Jackson 
Laboratory and subsequently housed and bred under the care of the Office of Lab Animal Resources at West 
Virginia University. Mice were on a 12/12 h light/dark cycle with food and water ad libitum. All animal studies 
were conducted with approval from the WVU institutional animal care and use committee and in accordance 
with Guide for the Care and Use of Laboratory Animals.
Figure 7. JAK-dependent regulation of the IL-6 cytokine family in murine astrocytes. (a) Primary murine 
astrocytes were pre-treated for 30 min with the JAK1/2 inhibitor, AZD1480 (2 µM) followed by stimulation with 
2.5 ng/ml of OSM. Cell lysates were then immunoblotted. (a–f) Cells were pretreated with AZD1480 for 30 min 
before stimulation with 1 μM thaps and 5 μM tunic for 4 hours. mRNA expression was analyzed by qPCR. 
*p ≤ 0.05, N = 3. Full-length blots are presented in Supplementary Fig. 4.
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Astrocyte and macrophage preparation. Primary astrocytes were prepared from postnatal day 0–1 
wild type C57BL/6 and PERK-CAGG-CreERTM mice as previously described40. In brief, pups were euthanized 
by decapitation, and the brains were collected into cold media. Meninges, cerebellum, and olfactory bulbs were 
removed and cerebra were collected. Tissue was disrupted by trituration and filtered through a 100 µm cell 
strainer. Cells were centrifuged at 300 × g for 5 min, resuspended in fresh astrocyte medium (Dulbecco’s Modified 
Eagle Medium (DMEM) with 10% fetal bovine serum (FBS), 16 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]
ethanesulfonic acid (HEPES), 1 × nonessential amino acids, 2 mM L-glutamine, 100 units/ml penicillin, 100 µg/
ml streptomycin, and 50 µg/ml gentamicin (Fisher Scientific), and transferred onto T-75 tissue culture flasks. The 
cultures were maintained for approximately 12–14 days at 37 °C in humidified 5% CO2/95% air atmosphere. One 
third of the media was changed every 3–4 days. Astrocytes were separated from microglia by shaking at 200 rpm 
for 2 h prior to plating astrocytes in 6-well plates for experiments.
Figure 8. JAK-dependent regulation of the IL-6 cytokine family in macrophages. (a–e) Primary BMD murine 
macrophages were pre-treated for 30 min with the JAK1/2 inhibitor, AZD1480 (2 µM) followed by stimulation 
with 1 μM thaps and 5 μM tunic for 4 hours. mRNA expression was analyzed by qPCR. *p ≤ 0.05, N = 3.
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To prepare murine bone marrow-derived (BMD) macrophages, bone marrow cells were harvested from 
the femur and tibia of the mice, passed through a 100 µm cell strainer, and red blood cells were lysed using 
Ammonium-Chloride-Potassium buffer. Cells were washed with PBS and cultured for 7 days in RPMI-1640 
medium (Gibco) supplemented with 10% FBS, 10% conditioned medium from L-929 cells, 2 mM glutamine, and 
2.5 µg/mL penicillin/streptomycin.
Quantitative RT-PCR analysis. Total RNA was isolated using TRIzol (Sigma Aldrich) according to man-
ufactures instructions. RNA was quantified using a NanoDrop (ThermoFisher), and 1 μg of RNA was used for 
cDNA synthesis using Moloney Murine Leukemia Virus (MMLV) reverse transcriptase (Promega). The cDNA 
was analyzed by quantitative PCR performed using the following probe-based assays from Integrated DNA 
Technologies: IL-6 (193420201), IL-11 (150336742), CNTF (186082805), LIF (186082793), OSM (150336738), 
and Hypoxanthine Phosphoribosyltransferase 1 (HPRT) (193420197). qPCR was performed using an ABI Step 
One Plus (Applied Biosystems). Reactions were carried out in 20 μL, analyzed using the ΔΔCt method, and 
normalized to HPRT.
Open reading frame identification. cDNA sequences were obtained from Ensemble and analyzed 
using NCBI ORFfinder. The IL-6 transcripts used in this analysis were human ENST00000404625.5 and mouse 
ENSMUST00000026845.11.
Western blotting. Cells were washed twice in cold PBS and collected in lysis buffer (20 mM Tris [pH 7.5], 
150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.5% NP-40, and 1 × phosphatase/protease inhibitor cocktail (Pierce), 
and the lysates were cleared by centrifugation for 15 min at 17000 × g at 4 °C. Protein concentrations were deter-
mined using the bicinchonicic acid assay (BCA) (Pierce). Equal amounts of protein from each sample were sol-
ubilized in Laemmli sample buffer (2% SDS) and heated for 5 min at 95 °C. Proteins were separated by 8% or 
10% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose. The membranes were incubated 
for 1 h in 5% non-fat milk in wash buffer (20 mM Tris base, 137 mM NaCl and 0.05% Tween-20 (TBST)) at 
room temperature, then incubated overnight at 4 °C with the primary antibodies diluted in 5% non-fat milk 
or 5% BSA, per the manufacturer’s recommendation. Antibodies from Cell Signaling Technologies: anti-PERK 
(3192), anti-eIF2α (5324), anti-P-eIF2α (3398), anti-ATF4 (11815), anti-GADD153 (CHOP; 7351). Monoclonal 
mouse anti-GAPDH (MAB374) was used as a loading control (EMD Millipore). The membranes were sub-
sequently washed and incubated with horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit IgG 
(diluted 1:3000; Jackson Immunoresearch Laboratories) for 1 h. The immune complexes were visualized by using 
enhanced chemiluminescence (Thermo Scientific).
ELISA. Cytokines were measured in 100 µl of medium according to the manufacturers’ protocol. ELISA kits 
for IL-6 (DY406), OSM (DY495-05), IL-11 (DY418), and LIF (DY449) were from R&D systems. ELISA for CNTF 
(MBS705237) was from MyBiosource.
Statistical tests. All experiments were done at least 3 independent times. Each data point on the graphs 
indicates an independent experiment, boxes indicate the average and error bars are standard deviation. Analysis 
of the experimental data was carried out using GraphPad Prism software and one-way ANOVA followed by the 
Tukey’s multiple comparison test or two-way ANOVA followed by Bonferroni multiple comparison test. The level 
of statistical significance is defined as p < 0.05.
Data availability
Data and related materials available on request.
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Figure 9. Summary of ER stress-induced regulation of the IL-6 family of cytokines in astrocytes and 
macrophages.
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